Edition:
India

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

21.00USD
25 Apr 2018
Change (% chg)

$-0.08 (-0.38%)
Prev Close
$21.08
Open
$21.14
Day's High
$21.14
Day's Low
$20.98
Volume
1,342
Avg. Vol
26,971
52-wk High
$31.75
52-wk Low
$15.15

Chart for

About

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients... (more)

Overall

No Ratios Available.

Financials

  ODT.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -- -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Odonate Therapeutics Q4 Loss Per Share $0.81

* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2017

14 Feb 2018

BRIEF-Odonate Holdings Llc Reports A 11.5 Pct Stake In Odonate Therapeutics As Of Dec 6

* Reports A 11.5 Pct Stake In Odonate Therapeutics Inc AS OF DEC 6 - SEC FILING Source text: (http://bit.ly/2AU3onq) Further company coverage:

19 Dec 2017

BRIEF-Boxer Capital LLC Reports 10.0 Pct Stake In Odonate Therapeutics As Of Dec 6

* BOXER CAPITAL LLC REPORTS 10.0 PERCENT STAKE IN ODONATE THERAPEUTICS INC AS OF DECEMBER 6 - SEC FILING

09 Dec 2017

BRIEF-Odonate Therapeutics Announces Pricing Of Initial Public Offering

* ODONATE THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

07 Dec 2017

Earnings vs. Estimates